NASH (nonalcoholic steatohepatitis)
GPTKB entity
Statements (34)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:disease
gptkb:liver_disease nonalcoholic fatty liver disease |
| gptkbp:abbreviation |
gptkb:nonalcoholic_steatohepatitis
|
| gptkbp:affectsOrgan |
liver
|
| gptkbp:canProgressTo |
liver cancer
cirrhosis |
| gptkbp:causedBy |
alcohol consumption
|
| gptkbp:characterizedBy |
inflammation
fat accumulation in liver liver cell damage |
| gptkbp:complication |
liver failure
hepatocellular carcinoma liver fibrosis |
| gptkbp:diagnosedBy |
liver biopsy
blood tests imaging studies |
| gptkbp:firstDescribed |
1980
|
| gptkbp:hasSubgroup |
NAFLD (nonalcoholic fatty liver disease)
|
| https://www.w3.org/2000/01/rdf-schema#label |
NASH (nonalcoholic steatohepatitis)
|
| gptkbp:ICD-10_code |
K75.81
|
| gptkbp:prevalence |
increasing worldwide
|
| gptkbp:relatedTo |
NAFLD (nonalcoholic fatty liver disease)
|
| gptkbp:riskFactor |
gptkb:type_2_diabetes
gptkb:metabolic_syndrome obesity hypertension dyslipidemia |
| gptkbp:treatment |
exercise
weight loss diet modification medications (under investigation) |
| gptkbp:bfsParent |
gptkb:CureApp
|
| gptkbp:bfsLayer |
7
|